Netik A, Hobel A, Rauschka H, Molzer B, Forss-Petter S, Berger J. Rolipram does not normalize very long-chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice. J Inherit Metabol Dis 2000; 23:615-624
Bauer J, Rauschka H, Lassmann H. Inflammation in the Nervous system: the human perspective. Glia 2001; 36:235-243
Rauschka H, Retzl J, Baumhackl U, Bankl HC, Salomonowitz E, Schmidbauer M. Subacute brainstem angioencephalopathy: a case report and review of the literature. J Neurol Sci. 2003 Apr 15; 208(1-2):101-4
Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Bruck W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.
J Neuropathol Exp Neurol. 2003 Jan;62(1):25-33.
Lassmann H, Reindl M, Rauschka H, Berger J, Aboul-Enein F, Berger T, Zurbriggen A, Lutterotti A, Bruck W, Weber JR, Ullrich R, Schmidbauer M, Jellinger K, Vandevelde M. A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions. Brain. 2003 Jun;126(Pt 6):1347-57
Rauschka H, Jellinger K, Lassmann H, Braier F, Schmidbauer M. Guillain-Barre syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnoses. Eur J Neurol. 2003 Sep;10(5):479-86
Rauschka H, Farina C, Sator P, Gudek S, Breier F, Schmidbauer M. Severe anaphylactic reaction to glatiramer acetate with specific IgE. Neurology. 2005 Apr 26;64(8):1481-2
Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005 Nov;128(Pt 11):2705-12.
Finsterer J, Stöllberger C, Avanzini M, Rauschka H Restrictive cardiomyopathy in dermatomyositis. Scand J Rheumatol. 2006 May-Jun;35(3):229-32.
Rauschka H, Colsch B, Baumann N, Wevers R, Schmidbauer M, Krammer M, Turpin JC, Lefevre M, Olivier C, Tardieu S, Krivit W, Moser H, Moser A, Gieselmann V, Zalc B, Cox T, Reuner U, Tylki-Szymanska A, Aboul-Enein F, LeGuern E, Bernheimer H, Berger J. Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology. 2006 Sep 12;67(5):859-63.
Finsterer J, Miltenberger G, Rauschka H, Janecke A. Novel C59T leader peptide mutation in the MPZ gene associated with late-onset, axonal, sensorimotor polyneuropathy. Eur J Neurol. 2006 Oct;13(10):1149-52.
Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Brück W, Lucchinetti C, Lassmann H. Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006 Dec;129(Pt 12):3165-72
Rauschka H, Aboul-Enein F, Bauer J, Nobis H, Lassmann H, Schmidbauer M. Acute cerebral white matter damage in lethal salicylate intoxication. Neurotoxicology. 2007 Jan;28(1):33-7
Kutzelnigg A, Faber-Rod JC, Bauer J, Lucchinetti CF, Sorensen PS, Laursen H, Stadelmann C, Brück W, Rauschka H, Schmidbauer M, Lassmann H. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol. 2007 Jan;17(1):38-44